Study of the effect of myrtus communis L.extract on Alzheimer's disease

Phase 3

• Conditions: Alzheimer's disease.; Other degenerative diseases of the nervous system; G30-G32

• Registration Number: IRCT20170702034861N8
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Age 50 to 85 years
MMSE score between 16 and 24
No drug abuse and alcohol dependence
Not taking anticoagulants
Ability to answer questions and no mental problems

Exclusion Criteria

depression

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
• Cognitive status of patients. Timepoint: Before and after 4 weeks of intervention. Method of measurement: Mini-Mental State Exam (MMSE) and Clinical Dementia Rating (CDR)questionnair.